These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11781359)

  • 1. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes.
    Mauvais-Jarvis F; Ueki K; Fruman DA; Hirshman MF; Sakamoto K; Goodyear LJ; Iannacone M; Accili D; Cantley LC; Kahn CR
    J Clin Invest; 2002 Jan; 109(1):141-9. PubMed ID: 11781359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival.
    Ueki K; Fruman DA; Brachmann SM; Tseng YH; Cantley LC; Kahn CR
    Mol Cell Biol; 2002 Feb; 22(3):965-77. PubMed ID: 11784871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
    Adochio R; Leitner JW; Hedlund R; Draznin B
    Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.
    Ueki K; Algenstaedt P; Mauvais-Jarvis F; Kahn CR
    Mol Cell Biol; 2000 Nov; 20(21):8035-46. PubMed ID: 11027274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling.
    Esposito DL; Li Y; Vanni C; Mammarella S; Veschi S; Della Loggia F; Mariani-Costantini R; Battista P; Quon MJ; Cama A
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1468-75. PubMed ID: 12679424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.
    Barbour LA; Mizanoor Rahman S; Gurevich I; Leitner JW; Fischer SJ; Roper MD; Knotts TA; Vo Y; McCurdy CE; Yakar S; Leroith D; Kahn CR; Cantley LC; Friedman JE; Draznin B
    J Biol Chem; 2005 Nov; 280(45):37489-94. PubMed ID: 16166093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.
    Luo J; Field SJ; Lee JY; Engelman JA; Cantley LC
    J Cell Biol; 2005 Aug; 170(3):455-64. PubMed ID: 16043515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.
    Aoki K; Matsui J; Kubota N; Nakajima H; Iwamoto K; Takamoto I; Tsuji Y; Ohno A; Mori S; Tokuyama K; Murakami K; Asano T; Aizawa S; Tobe K; Kadowaki T; Terauchi Y
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E842-53. PubMed ID: 19176357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse.
    Kerouz NJ; Hörsch D; Pons S; Kahn CR
    J Clin Invest; 1997 Dec; 100(12):3164-72. PubMed ID: 9399964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance.
    del Rincon JP; Iida K; Gaylinn BD; McCurdy CE; Leitner JW; Barbour LA; Kopchick JJ; Friedman JE; Draznin B; Thorner MO
    Diabetes; 2007 Jun; 56(6):1638-46. PubMed ID: 17363744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.
    Folli F; Saad MJ; Backer JM; Kahn CR
    J Clin Invest; 1993 Oct; 92(4):1787-94. PubMed ID: 7691886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells.
    Montagnani M; Ravichandran LV; Chen H; Esposito DL; Quon MJ
    Mol Endocrinol; 2002 Aug; 16(8):1931-42. PubMed ID: 12145346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients.
    Lefai E; Roques M; Vega N; Laville M; Vidal H
    Biochem J; 2001 Nov; 360(Pt 1):117-26. PubMed ID: 11695998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.
    Hashimoto H; Arai T; Takeguchi A; Hioki K; Ohnishi Y; Kawai K; Ito M; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
    Comp Med; 2006 Jun; 56(3):176-87. PubMed ID: 16774126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
    Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
    Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Knockout mouse models for type 2 diabetes. Mice with insulin resistance].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():64-9. PubMed ID: 12355825
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase.
    Rajala RV; McClellan ME; Chan MD; Tsiokas L; Anderson RE
    Biochemistry; 2004 May; 43(19):5637-50. PubMed ID: 15134438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
    Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.
    Fasshauer M; Klein J; Kriauciunas KM; Ueki K; Benito M; Kahn CR
    Mol Cell Biol; 2001 Jan; 21(1):319-29. PubMed ID: 11113206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
    Kido Y; Burks DJ; Withers D; Bruning JC; Kahn CR; White MF; Accili D
    J Clin Invest; 2000 Jan; 105(2):199-205. PubMed ID: 10642598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.